Use of Glucagon-like peptide 2 (GLP-2) analogs in inflammatory bowel disease

• Автори: Dobromiła Osuch (Автор), Piotr Zatyka (Автор), Adam Słomczyński (Автор), Agata Pawłowska (Автор), Michal Rabenda (Автор), Piotr Janik (Автор), Dominika Opala (Автор)
• Формат: Книга
• Опубліковано: Nicolaus Copernicus University in Toruń, 2024-08-01T00:00:00Z.
• Предмети: article
• Онлайн доступ: Connect to this object online.

Introduction: Inflammatory bowel disease (IBD) is a chronic condition that involves long-term treatment and chronic idiopathic inflammation within the gastrointestinal tract. The predominant forms of IBD are: Crohn's disease and ulcerative colitis. These diseases cause significant physical as w...